AllianceBernstein’s Bionano Genomics BNGO Stock Holding History

AllianceBernstein’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-754	Closed	-$502K	–	3176
2023 Q1	$502K	Buy	754 +121	+19%	+$107K	﹤0.01%	2574
2022 Q4	$554K	Hold	633	–	–	﹤0.01%	2576
2022 Q3	$695K	Hold	633	–	–	﹤0.01%	2484
2022 Q2	$524K	Hold	633	–	–	﹤0.01%	2665
2022 Q1	$979K	Buy	633 +2	+0.3%	+$2.7K	﹤0.01%	2442
2021 Q4	$1.13M	Hold	631	–	–	﹤0.01%	2411
2021 Q3	$2.08M	Hold	631	–	–	﹤0.01%	2146
2021 Q2	$2.78M	Buy	+631	New	+$2.49M	﹤0.01%	1981

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AllianceBernstein's BNGO Position: Q2 2023 in Review

AllianceBernstein sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 754 shares — an estimated $502K sold.

AllianceBernstein first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $2.78M in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

AllianceBernstein reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
AllianceBernstein sold 754 Bionano Genomics shares in Q2 2023, an estimated $502K.
AllianceBernstein first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
AllianceBernstein's Bionano Genomics position peaked at $2.78M in Q2 2021.
108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on AllianceBernstein's 13F filing for Q2 2023, filed 15 Aug 2023.